Softgel Formulation Strategies For Challenging Oral Compounds

Poor solubility and limited permeability continue to challenge the success of oral drug development, with a growing majority of candidate molecules struggling to achieve reliable absorption. Addressing these barriers early is critical to avoiding downstream risks such as inconsistent exposure, high dosing requirements, and patient variability.

Softgel technologies offer a versatile approach for improving bioavailability, particularly for compounds in the more challenging Biopharmaceutics Classification System categories. By enabling drugs to be delivered in a dissolved or near-dissolved state, and supporting lipid-based or self-emulsifying systems, softgels help enhance both solubility and permeability. This can lead to more consistent absorption, reduced variability, and improved therapeutic outcomes.

Careful formulation design also plays a key role in stability and usability, protecting sensitive compounds while enabling more flexible dosing regimens. As pipelines increasingly feature complex molecules, evaluating formulation strategies alongside molecular development can help unlock full clinical and commercial potential. Explore how these approaches can strengthen your oral drug development strategy.